BRIEF-MF International Announces Closing Of Initial Public Offering-March 2024-www.financetom.com

BRIEF-MF International Announces Closing Of Initial Public Offering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-MF International Announces Closing Of Initial Public Offering

Apr 24, 2024 3:25 PM

April 24 (Reuters) - mF International Limited ( MFI ):

* MF INTERNATIONAL LIMITED ANNOUNCES CLOSING OF INITIAL

PUBLIC

OFFERING

Source text for Eikon:

Further company coverage:

Previous page： Microsoft hires former GE CFO Carolina Dybeck Happe as operations chief Next page： Charter adds Warner Bros Discovery's streaming service at no extra charge

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Microsoft hires former GE CFO Carolina Dybeck Happe as operations chief

Sep 12, 2024

Sept 12 (Reuters) - Microsoft ( MSFT ) said on Thursday appointed former GE finance chief Carolina Dybeck Happe as its chief operations officer. ...

Charter adds Warner Bros Discovery's streaming service at no extra charge

Sep 12, 2024

(Reuters) - Charter Communications ( CHTR ) will provide Warner Bros Discovery's ( WBD ) Max streaming service and Discovery+ at no additional charge, the companies said on Thursday, potentially boosting the cable and broadband company's user base. Shares of Warner Bros Discovery ( WBD ) rose about 7% in morning trading, while those of Charter gained more than 2%....

DirecTV says Disney dispute costing it customers

Sep 12, 2024

Sept 12 (Reuters) - DirecTV said its licensing dispute with Walt Disney ( DIS ) is costing its customers, in remarks Thursday at the Goldman Sachs Communacopia + Technology conference. DirecTV subscribers lost access to Disney's ( DIS ) networks on Sept. 1, after the two sides failed to reach a new distribution deal. ...

Aura Biosciences Touts Promising Data From Eye Cancer Candidate

Sep 12, 2024

Thursday, Aura Biosciences, Inc. ( AURA ) revealed Phase 2 end-of-study results evaluating bel-sar (AU-011) for the first-line treatment of early-stage choroidal melanoma (CM), a vision and ocular cancer. The Phase 2 results demonstrated that bel-sar achieved an 80% tumor control rate (n=8/10) among Phase 3-eligible patients who received the therapeutic regimen, with complete cessation of growth following treatment among responders...